Associated Genetic Biomarkers
NCI Definition: A solitary adenocarcinoma arising from the lung measuring 3 cm or less. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous. 
There are 4 clinical trials for bronchioloalveolar carcinoma, of which 4 are open and 0 are completed or closed. Of the trials that contain bronchioloalveolar carcinoma as an inclusion criterion, 4 are phase 2 (4 open).
EGFR is the most frequent gene inclusion criterion for bronchioloalveolar carcinoma clinical trials .
Nivolumab, docetaxel, and ipilimumab are the most common interventions in bronchioloalveolar carcinoma clinical trials.
Significant Genes in Bronchioloalveolar Carcinoma
CD274 is an inclusion eligibility criterion in 1 clinical trial for bronchioloalveolar carcinoma, of which 1 is open and 0 are closed. Of the trial that contains CD274 status and bronchioloalveolar carcinoma as inclusion criteria, 1 is phase 2 (1 open) .
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.